DT
PT
Subscribe To Print Edition About The Tribune Code Of Ethics Download App Advertise with us Classifieds
search-icon-img
search-icon-img
Advertisement

Cosmetics firm at Himachal's Baddi told to stop operation

Tribune News Service Solan, June 17 A cosmetics company at Baddi in the district has been directed to stop operation, as it was undertaking manufacturing in the absence of technical persons in violation of the provisions of the Drugs and...
  • fb
  • twitter
  • whatsapp
  • whatsapp
Advertisement

Tribune News Service

Advertisement

Solan, June 17

A cosmetics company at Baddi in the district has been directed to stop operation, as it was undertaking manufacturing in the absence of technical persons in violation of the provisions of the Drugs and Cosmetics Act.

Advertisement

“An inspection, conducted by the Drugs Inspector on June 15 at Ozone Pharmaceuticals, Baddi, revealed that the company was manufacturing and testing cosmetics in the absence of technical persons in quality control and production. The firm was found not complying with the provisions of Schedule M-II of the Act,” said Manish Kapoor, Deputy Drugs Controller-cum-licensing authority.

“The management has been issued a show-cause notice and directed to stop manufacturing till the compliance of the rules is done. The sale of cosmetics products has also been stopped and any violation will attract Section 18(c) of the Act,” said Kapoor.

Advertisement

As per the norms, no manufacturing and sale can take place in a unit without the presence of quality control and production officials. They are supposed to ensure the adherence of the quality and production norms. While the company had no quality control official for the past about two months, the production official had also left. No official has been appointed to oversee the manufacturing.

Officials of the Drugs Control Administration (DCA) are inspecting pharmaceutical units to ensure that norms are adhered to.

Advertisement
Advertisement
Advertisement
Advertisement
tlbr_img1 Classifieds tlbr_img2 Videos tlbr_img3 Premium tlbr_img4 E-Paper tlbr_img5 Shorts